• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在心脏再同步治疗患者中,无症状性心房颤动与P波时限指数相关。

Silent atrial fibrillation is associated with P-wave duration index in patients with cardiac resynchronisation therapy.

作者信息

Demirtas Abdullah Orhan, Icen Yahya Kemal, Donmez Yurdaer, Koca Hasan, Kaypakli Onur, Koc Mevlut

机构信息

Cardiology Department, Health Sciences University, Adana City Hospital, Adana, Turkey.

Cardiology Department, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey.

出版信息

Arch Med Sci Atheroscler Dis. 2019 May 27;4:e74-e81. doi: 10.5114/amsad.2019.85375. eCollection 2019.

DOI:10.5114/amsad.2019.85375
PMID:31211273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6554754/
Abstract

INTRODUCTION

Atrial fibrillation (AF) attacks can be silent, symptomatic, or emerge with its complications in pacemaker-implanted patient groups. P-wave duration index (PWDI), a novel parameter, is calculated by dividing the P-wave duration (PWD) by the PR interval. This study aimed to investigate the relation between PWDI and silent AF development in cardiac resynchronisation therapy defibrillator (CRT-D)-applied patients.

MATERIAL AND METHODS

The study population consisted of 181 CRT-D device-implanted patients. Atrial fibrillation attacks that last at least 30 s with no symptoms were accepted as silent AF.

RESULTS

Patients were separated into two groups: "with silent AF" and "without silent AF". The without silent AF group comprised 121 patients (mean age: 62.9 ±8.7 years, 62% male). The with silent AF group included 60 patients (mean age: 67.9 ±9.7 years, 60% male). The silent AF group had significantly higher mean age ( = 0.001). PR duration was significantly higher in the without silent AF group ( = 0.001). Patients with first-degree IAB and PWDI values were significantly higher in the with silent AF group (-values were 0.001 and < 0.001, respectively). Age (OR = 1.073, 95% CI: 1.028-1.119, = 0.001) and PWDI (OR = 1.053, 95% CI: 1.028-1.078, < 0.001) were detected as independent predictors for silent AF in the binomial logistic regression analysis. In the ROC analysis, a PWDI cut-off value of 0.67 determined silent AF with 81.7% sensitivity and 51.4% specificity (AUC = 0.701, < 0.001).

CONCLUSIONS

P-wave duration index was significantly associated with silent AF in patients with CRT-D.

摘要

引言

在植入起搏器的患者群体中,房颤(AF)发作可能是无症状的、有症状的,或者伴有并发症出现。P波时限指数(PWDI)是一个新参数,通过将P波时限(PWD)除以PR间期来计算。本研究旨在探讨PWDI与接受心脏再同步治疗除颤器(CRT-D)的患者无症状房颤发生之间的关系。

材料与方法

研究人群包括181例植入CRT-D设备的患者。持续至少30秒且无症状的房颤发作被视为无症状房颤。

结果

患者被分为两组:“有无症状房颤”组和“无无症状房颤”组。无无症状房颤组包括121例患者(平均年龄:62.9±8.7岁,62%为男性)。有无症状房颤组包括60例患者(平均年龄:67.9±9.7岁,60%为男性)。无症状房颤组的平均年龄显著更高(P=0.001)。无无症状房颤组的PR间期显著更长(P=0.001)。一度房室传导阻滞和PWDI值在有无症状房颤组患者中显著更高(P值分别为0.001和<0.001)。在二项逻辑回归分析中,年龄(OR=1.073,95%CI:1.028-1.119,P=0.001)和PWDI(OR=1.053,95%CI:1.028-1.078,P<0.001)被检测为无症状房颤的独立预测因素。在ROC分析中,PWDI临界值为0.67时,诊断无症状房颤的敏感性为81.7%,特异性为51.4%(AUC=0.701,P<0.001)。

结论

P波时限指数与接受CRT-D治疗的患者无症状房颤显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a04/6554754/e3dd7dae1b37/AMS-AD-4-36749-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a04/6554754/0185144a1ac1/AMS-AD-4-36749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a04/6554754/b3f715e76a8a/AMS-AD-4-36749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a04/6554754/e3dd7dae1b37/AMS-AD-4-36749-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a04/6554754/0185144a1ac1/AMS-AD-4-36749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a04/6554754/b3f715e76a8a/AMS-AD-4-36749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a04/6554754/e3dd7dae1b37/AMS-AD-4-36749-g003.jpg

相似文献

1
Silent atrial fibrillation is associated with P-wave duration index in patients with cardiac resynchronisation therapy.在心脏再同步治疗患者中,无症状性心房颤动与P波时限指数相关。
Arch Med Sci Atheroscler Dis. 2019 May 27;4:e74-e81. doi: 10.5114/amsad.2019.85375. eCollection 2019.
2
Association of P wave duration index with atrial fibrillation recurrence after cryoballoon catheter ablation.P波时限指数与冷冻球囊导管消融术后房颤复发的相关性
J Electrocardiol. 2018 Mar-Apr;51(2):182-187. doi: 10.1016/j.jelectrocard.2017.09.016. Epub 2017 Oct 9.
3
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke.心电图预测隐匿性心房颤动在不明原因脑卒中中的作用。
Heart Lung Circ. 2019 Nov;28(11):1664-1669. doi: 10.1016/j.hlc.2018.10.020. Epub 2018 Nov 16.
4
Relationship between paroxysmal atrial fibrillation and a novel electrocardiographic parameter P wave peak time.阵发性心房颤动与一种新型心电图参数P波峰时间之间的关系。
J Electrocardiol. 2019 Nov-Dec;57:81-86. doi: 10.1016/j.jelectrocard.2019.09.006. Epub 2019 Sep 4.
5
Impact of hemodialysis on P-wave amplitude, duration, and dispersion.血液透析对P波振幅、时限及离散度的影响。
Indian Pacing Electrophysiol J. 2007 Apr 1;7(2):85-96.
6
Interatrial Block Predicts Atrial Fibrillation and Total Mortality in Patients with Cardiac Resynchronization Therapy.房间隔阻滞预测心脏再同步化治疗患者的心房颤动和总死亡率。
Cardiology. 2020;145(11):720-729. doi: 10.1159/000509916. Epub 2020 Oct 6.
7
Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.心脏再同步除颤器治疗阵发性心房颤动患者的多中心RENEWAL 3 AVT临床研究结果。
J Cardiovasc Electrophysiol. 2006 May;17(5):520-5. doi: 10.1111/j.1540-8167.2006.00440.x.
8
Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1.房间传导阻滞预测 1 型肌强直性营养不良的心房颤动。
Neuromuscul Disord. 2018 Apr;28(4):327-333. doi: 10.1016/j.nmd.2018.01.010. Epub 2018 Jan 31.
9
Predictive value of P-wave duration and dispersion in post coronary artery bypass surgery atrial fibrillation.冠状动脉搭桥术后房颤中P波时限及离散度的预测价值
ARYA Atheroscler. 2012 Summer;8(2):59-62.
10
Coefficient of variation of P-wave duration measured using an automated measurement system predicts recurrence of atrial fibrillation.使用自动测量系统测量的P波时限变异系数可预测房颤复发。
J Electrocardiol. 2019 Mar-Apr;53:79-84. doi: 10.1016/j.jelectrocard.2019.01.089. Epub 2019 Jan 25.

引用本文的文献

1
Multiple anthropometric measures and proarrhythmic 12-lead ECG indices: A mendelian randomization study.多种人体测量指标与致心律失常 12 导联心电图指数:一项孟德尔随机研究。
PLoS Med. 2023 Aug 8;20(8):e1004275. doi: 10.1371/journal.pmed.1004275. eCollection 2023 Aug.
2
Usefulness of P-wave duration in patients with sick sinus syndrome as a predictor of atrial fibrillation.病态窦房结综合征患者中P波时限作为心房颤动预测指标的效用
J Arrhythm. 2021 Jul 21;37(5):1220-1226. doi: 10.1002/joa3.12604. eCollection 2021 Oct.

本文引用的文献

1
Association of P wave duration index with atrial fibrillation recurrence after cryoballoon catheter ablation.P波时限指数与冷冻球囊导管消融术后房颤复发的相关性
J Electrocardiol. 2018 Mar-Apr;51(2):182-187. doi: 10.1016/j.jelectrocard.2017.09.016. Epub 2017 Oct 9.
2
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
3
Electrocardiographic Advanced Interatrial Block and Atrial Fibrillation Risk in the General Population.
普通人群中心电图高级房内阻滞与心房颤动风险
Am J Cardiol. 2016 Jun 1;117(11):1755-9. doi: 10.1016/j.amjcard.2016.03.013. Epub 2016 Mar 18.
4
Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes.无症状性与症状性心房颤动:年龄/性别差异及心血管结局的系统评价
Int J Cardiol. 2015 Jul 15;191:172-7. doi: 10.1016/j.ijcard.2015.05.011. Epub 2015 May 7.
5
Advanced interatrial block as a substrate of supraventricular tachyarrhythmias: a well recognized syndrome.高级房内传导阻滞作为室上性快速性心律失常的基质:一种公认的综合征。
J Electrocardiol. 2015 Mar-Apr;48(2):135-40. doi: 10.1016/j.jelectrocard.2014.12.015. Epub 2015 Jan 9.
6
Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation.对大量当代新发非瓣膜性心房颤动患者队列的患病率、发病率、管理及结局进行的前瞻性全国性研究。
J Am Heart Assoc. 2015 Jan 21;4(1):e001486. doi: 10.1161/JAHA.114.001486.
7
Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion.高度房室传导阻滞与药物转复心房颤动后复发相关。
Cardiovasc Ther. 2014 Apr;32(2):52-6. doi: 10.1111/1755-5922.12063.
8
Short-term repeatability of electrocardiographic P wave indices and PR interval.心电图P波指数和PR间期的短期重复性
J Electrocardiol. 2014 Mar-Apr;47(2):257-63. doi: 10.1016/j.jelectrocard.2013.11.007. Epub 2013 Nov 25.
9
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).2013年欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗指南:欧洲心脏病学会(ESC)心脏起搏与再同步治疗特别工作组。与欧洲心律协会(EHRA)合作制定。
Eur Heart J. 2013 Aug;34(29):2281-329. doi: 10.1093/eurheartj/eht150. Epub 2013 Jun 24.
10
Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.氧化应激与心房颤动:NADPH 氧化酶的新作用
J Mol Cell Cardiol. 2013 Sep;62:72-9. doi: 10.1016/j.yjmcc.2013.04.019. Epub 2013 May 2.